Erythrox is a federally licensed dealer manufacturing pharmaceutical-grade cocaine hydrochloride and coca-derived APIs — supplied exclusively to hospitals, pharmacists, practitioners, licensed dealers, and authorized researchers across Canada.
Every gram we manufacture exists inside a federal framework. Our Controlled Drugs and Substances Dealer's Licence defines exactly what we may do — and exactly who we may serve. We treat those boundaries as our brand.
No sale to the general public. All transactions are verified against Health Canada licensing records, reported per regulatory requirement, and reconciled against annual production quota. Displayed licence details are illustrative for this concept.
End-to-end capability under one roof and one licence — botanical import, extraction, synthesis, analytical release, and finished formulation support.
Pharmaceutical-grade API for topical anesthetic formulations and authorized research. Released against full USP monograph testing.
Licensed import of Erythroxylum coca with primary extraction performed in-facility under full serialized reconciliation.
HPLC assay, GC-MS impurity profiling, residual solvents, and certificate of analysis issued on every batch — yours or ours.
Development and fill of topical anesthetic solutions (4% / 10%) and clinical trial materials for licensed partners.
Every gram is weighed twice, sealed once, and signed for — from vault door to responsible person in charge.
Standard Operating Procedure · ERX-SOP-014
A controlled substance operation is judged on what it can prove. Our facility is engineered around evidence — every gram weighed, every movement logged, every batch traceable to source.
Mean release assay across all API lots, tested against the USP monograph.
Gram-level reconciliation of production against Health Canada annual quota.
Level-9 security vault with continuous surveillance and dual-custody access.
Dedicated zones for extraction, synthesis, QC, and secure storage.
Dependable supply of topical anesthetic API and finished-form support for surgical and ENT programs, with provincial procurement documentation.
Licensed pharmacy and practitioner supply with verified credentials, secure delivery, and complete regulatory paperwork on every order.
Reference-standard material for s.56(1) exemption holders — supporting pharmacology, toxicology, and harm-reduction research programs.
B2B API supply and contract manufacturing for fellow dealer's-licence holders and pharmaceutical development partners.
A short qualification takes two minutes. Our compliance desk reviews every inquiry within two business days.
Verified licence holders can browse released batches, review certificates of analysis, and submit purchase orders directly.
Because our licence restricts who we may serve, every relationship begins with a short eligibility review. Nothing here is binding — it simply lets our compliance desk respond with precision.
Sale of controlled substances is restricted by federal law. This tells us which framework applies to you.
Select the option that fits best to continue.
Approximate is fine — our compliance desk verifies everything against Health Canada records before any supply discussion.
Select your licensing position to continue.
Select all that apply.
Select at least one requirement to continue.
Add your name and an institutional email so we can reply.
Access is restricted to verified holders of an eligible licence or exemption under the CDSA. This concept demonstrates the verified purchasing experience — all batches, prices, and credentials shown are illustrative.
Credentials are checked against Health Canada licensing records before catalog access is granted.
Enter your organization, credential type, and licence number.
ERX-01 · CAS 53-21-4 · SELECT A BATCH TO ORDER
Select a batch and enter a quantity within available stock and quota.
Your order enters compliance review before release. Nothing ships until credentials, quota, and custody documents are cleared.
ERX-PO-2026-0000